EC Number   |
Title |
Organism |
|---|
    1.6.5.2 | Affinity-based small fluorescent probe for NAD(P)H quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation |
Homo sapiens |
| 1.6.5.2 | An NAD(P)H quinone oxidoreductase 1 (NQO1) enzyme responsive nanocarrier based on mesoporous silica nanoparticles for tumor targeted drug delivery in vitro and in vivo |
Homo sapiens |
| 1.6.5.2 | Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones excellent substrates for NAD(P)H quinone oxidoreductase 1 |
Homo sapiens |
| 1.6.5.2 | C609T polymorphism of NADPH quinone oxidoreductase 1 correlates clinical hematological toxicities in lung cancer patients treated with amrubicin |
Homo sapiens |
| 1.6.5.2 | Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H quinone oxidoreductase 1 (NQO1) |
Homo sapiens |
| 1.6.5.2 | Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H quinone oxidoreductase |
Homo sapiens |
| 1.6.5.2 | Docosahexaenoic acid induces expression of heme oxygenase-1 and NAD(P)H Quinone oxidoreductase through activation of Nrf2 in human mammary epithelial cells |
Homo sapiens |
| 1.6.5.2 | Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H quinone oxidoreductase 1 in Hepa1c1c7 cells |
Mus musculus |
| 1.6.5.2 | Human glutathione S-transferases- and NAD(P)H quinone oxidoreductase 1-catalyzed inactivation of reactive quinoneimines of amodiaquine and N-desethylamodiaquine Possible implications for susceptibility to amodiaquine-induced liver toxicity |
Homo sapiens |
| 1.6.5.2 | Leflunomide induces NAD(P)H quinone dehydrogenase 1 enzyme via the aryl hydrocarbon receptor in neonatal mice |
Mus musculus |
